Home Tools
Log in
Cart

DPP-4

Dipeptidyl peptidase-4 (DPP-4) inhibitors are a relatively new class of oral diabetes drugs, usually prescribed for people with type 2 diabetes.
Signaling Pathways | Target | TargetMol
Cat. No. Product name CAS No. Purity Chemical Structure
T11248 Evogliptin tartrate 1222102-51-3 98%
Evogliptin tartrate
Evogliptin tartrate has potential for anti-atherosclerosis therapy that targets arterial inflammation. Evogliptin tartrate is a potent, orally bioavailable and s...
T6203 Saxagliptin 361442-04-8 99.95%
Saxagliptin
Saxagliptin (BMS-477118) is a selective and reversible DPP4 inhibitor with IC50 of 26 nM.
T2401 Alogliptin Benzoate 850649-62-6 99.95%
Alogliptin Benzoate
Alogliptin Benzoate (SYR 322)(SYR 322), an effective and specific DPP-4 inhibitor (IC50<10 nM), exhibits greater than 10, 000-fold selectivity over DPP-8/9. Alog...
T0191 Linagliptin 668270-12-0 99.95%
Linagliptin
Linagliptin (BI 1356) is a potent, orally bioavailable dihydropurinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity.
T16838 Saikogenin A 5092-09-1 99.86%
Saikogenin A
Saikogenin A is a dipeptidyl peptidase-4 inhibitor.
T0178 Saxagliptin hydrate 945667-22-1 99.8%
Saxagliptin hydrate
Saxagliptin hydrate (Onglyza hydrate) is a selective and reversible DPP4 inhibitor (IC50: 26 nM; Ki: 1.3 nM).
T6192 Alogliptin 850649-61-5 99.77%
Alogliptin
Alogliptin (SYR-322)(SYR-322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10, 000-fold selectivity over DPP-8 and DPP-9....
T23358 Sitagliptin phosphate 654671-78-0 99.72%
Sitagliptin phosphate
Sitagliptin phosphate (MK-0431 phosphate) is a dipeptidyl peptidase-4 (DPP4) inhibitor.
T2316 Omarigliptin 1226781-44-7 99.70%
Omarigliptin
Omarigliptin (MK-3102) has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal Insufficiency.
T0242L Sitagliptin phosphate monohydrate 654671-77-9 99.65%
Sitagliptin phosphate monohydrate
Sitagliptin phosphate monohydrate (MK-0431 phosphate monohydrate) is a potent inhibitor of DPP-IV with IC50 of 19 nM in Caco-2 cell extracts.
T15079 DBPR108 1186426-66-3 99.65%
DBPR108
DBPR108 is an orally bioavailable dipeptide-derived DPP4 inhibitor (IC50: 15 nM) and it has no inhibition on DDP8 and DPP9.
T1581 Picolamine 3731-52-0 99.64%
Picolamine
Picolamine acts as a potential inhibitor of DPP-4.
T0242 Sitagliptin 486460-32-6 99.4%
Sitagliptin
Sitagliptin (MK0431), a new oral hypoglycemic (anti-diabetic drug), is a new dipeptidyl peptidase-4 (DPP-4) inhibitor. This enzyme-inhibiting drug is used either...
T68053 Denagliptin 483369-58-0 99.37%
Denagliptin
Denagliptin is a small molecule dipeptidyl peptidase IV (DPP-4) inhibitor for the treatment of endocrine Ü metabolic diseases and can be used in the study of typ...
T25340 Diprotin A 90614-48-5 99.29%
Diprotin A
Diprotin A (Ile-Pro-Ile) (Ile-Pro-Ile) is a dipeptidyl peptidase IV (DPP-IV) inhibitor.
T21979 P32/98 hemifumarate 251572-86-8 99.07%
P32/98 hemifumarate
P32/98 hemifumarate is a dipeptidyl peptidase IV (DPP4) inhibitor with hypoglycemic properties that improves insulin sensitivity and β-cell responsiveness in the...
T12710 Retagliptin Phosphate 1256756-88-3 98.97%
Retagliptin Phosphate
Retagliptin Phosphate (SP 2086) is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes.
T6237 Trelagliptin 865759-25-7 98.94%
Trelagliptin
Trelagliptin (SYR-472) is a highly specific and long-acting DPP-4 inhibitor.
T11526 DPP-IV-IN-2 136259-18-2 98.93%
DPP-IV-IN-2
DPP-IV-IN-2 (H-Lys(4-nitro-Z)-pyrrolidide) is an inhibitor of both DP8/9 and dipeptidyl peptidase IV (IC50s: 0.1 and 0.95 μM).
TN1418 Azaleatin 529-51-1 98.62%
Azaleatin
Azaleatin is a natural product from Rhododendron simsii. Azaleatin is a dipeptidyl peptidase-IV inhibitor. Azaleatin can be used for type-2 diabetes and obesity ...
Evogliptin tartrate
T11248
Evogliptin tartrate has potential for anti-atherosclerosis therapy that targets arterial inflammation. Evogliptin tartrate is a potent, orally bioavailable and s...
Saxagliptin
T6203
Saxagliptin (BMS-477118) is a selective and reversible DPP4 inhibitor with IC50 of 26 nM.
Alogliptin Benzoate
T2401
Alogliptin Benzoate (SYR 322)(SYR 322), an effective and specific DPP-4 inhibitor (IC50<10 nM), exhibits greater than 10, 000-fold selectivity over DPP-8/9. Alog...
Linagliptin
T0191
Linagliptin (BI 1356) is a potent, orally bioavailable dihydropurinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity.
Saikogenin A
T16838
Saikogenin A is a dipeptidyl peptidase-4 inhibitor.
Saxagliptin hydrate
T0178
Saxagliptin hydrate (Onglyza hydrate) is a selective and reversible DPP4 inhibitor (IC50: 26 nM; Ki: 1.3 nM).
Alogliptin
T6192
Alogliptin (SYR-322)(SYR-322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10, 000-fold selectivity over DPP-8 and DPP-9....
Sitagliptin phosphate
T23358
Sitagliptin phosphate (MK-0431 phosphate) is a dipeptidyl peptidase-4 (DPP4) inhibitor.
Omarigliptin
T2316
Omarigliptin (MK-3102) has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal Insufficiency.
Sitagliptin phosphate monohydrate
T0242L
Sitagliptin phosphate monohydrate (MK-0431 phosphate monohydrate) is a potent inhibitor of DPP-IV with IC50 of 19 nM in Caco-2 cell extracts.
DBPR108
T15079
DBPR108 is an orally bioavailable dipeptide-derived DPP4 inhibitor (IC50: 15 nM) and it has no inhibition on DDP8 and DPP9.
Picolamine
T1581
Picolamine acts as a potential inhibitor of DPP-4.
Sitagliptin
T0242
Sitagliptin (MK0431), a new oral hypoglycemic (anti-diabetic drug), is a new dipeptidyl peptidase-4 (DPP-4) inhibitor. This enzyme-inhibiting drug is used either...
Denagliptin
T68053
Denagliptin is a small molecule dipeptidyl peptidase IV (DPP-4) inhibitor for the treatment of endocrine Ü metabolic diseases and can be used in the study of typ...
Diprotin A
T25340
Diprotin A (Ile-Pro-Ile) (Ile-Pro-Ile) is a dipeptidyl peptidase IV (DPP-IV) inhibitor.
P32/98 hemifumarate
T21979
P32/98 hemifumarate is a dipeptidyl peptidase IV (DPP4) inhibitor with hypoglycemic properties that improves insulin sensitivity and β-cell responsiveness in the...
Retagliptin Phosphate
T12710
Retagliptin Phosphate (SP 2086) is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes.
Trelagliptin
T6237
Trelagliptin (SYR-472) is a highly specific and long-acting DPP-4 inhibitor.
DPP-IV-IN-2
T11526
DPP-IV-IN-2 (H-Lys(4-nitro-Z)-pyrrolidide) is an inhibitor of both DP8/9 and dipeptidyl peptidase IV (IC50s: 0.1 and 0.95 μM).
Azaleatin
TN1418
Azaleatin is a natural product from Rhododendron simsii. Azaleatin is a dipeptidyl peptidase-IV inhibitor. Azaleatin can be used for type-2 diabetes and obesity ...
1 2
TargetMol